Tapewire

NYSE · USD

RCUS

Arcus Biosciences, Inc.

Export transactions ↓
Tapewire entity
4104
SEC CIK
0001724521
Parsed reports
290

Last 12 months

Inside the activity.

0 purchase rows · 36 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 2025017
Jan 202603
Feb 202600
Mar 202600
Apr 202600
May 202601
Jun 202605
Jul 202603
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 17, 2025 Filed Dec 18, 2025 17:35 UTC
Tang Carolyn C.General Counsel
SaleCommon Stock 6,810 $22.16 $150,906.20
Disclosure

SEC source: 0001836662-25-000005 · wk-form4_1766097342.xml · nonDerivative · entry 2

Tang Carolyn C. · CIK 0001836662 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,734

F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.

F5 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F4 · balance_after: Includes the unvested portion of the reporting person's RSU grants.

Read SEC document
December 17, 2025 Filed Dec 18, 2025 22:35 UTC
Azoy AlexanderChief Accounting Officer
SaleCommon Stock 2,113 $22.16 $46,823.02
Disclosure

SEC source: 0001771961-25-000014 · wk-form4_1766097326.xml · nonDerivative · entry 2

Azoy Alexander · CIK 0001771961 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,874

F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Includes the unvested portion of the reporting person's RSU grants.

Read SEC document
December 17, 2025 Filed Dec 18, 2025 22:35 UTC
Goeltz II Robert C.Chief Financial Officer
SaleCommon Stock 5,960 $22.16 $132,070.62
Disclosure

SEC source: 0001653881-25-000011 · wk-form4_1766097319.xml · nonDerivative · entry 2

Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,476

F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Includes the unvested portion of the reporting person's RSU grants.

Read SEC document
December 17, 2025 Filed Dec 18, 2025 22:35 UTC
Jarrett JenniferChief Operating Officer
SaleCommon Stock 9,983 $22.16 $221,218.29
Disclosure

SEC source: 0001671311-25-000009 · wk-form4_1766097311.xml · nonDerivative · entry 2

Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 193,024

F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Includes the unvested portion of the reporting person's RSU grants.

Read SEC document
December 17, 2025 Filed Dec 18, 2025 22:35 UTC
Jaen Juan C.President
SaleCommon Stock 9,983 $22.16 $221,218.29
Disclosure

SEC source: 0001422996-25-000015 · wk-form4_1766097305.xml · nonDerivative · entry 2

Jaen Juan C. · CIK 0001422996 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 346,012

F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Includes the unvested portion of the reporting person's RSU grants.

Read SEC document
December 17, 2025 Filed Dec 18, 2025 22:35 UTC
ROSEN TERRY JDirector · Chief Executive Officer
SaleCommon Stock 25,744 $22.16 $570,474.17
Disclosure

SEC source: 0001182473-25-000005 · wk-form4_1766097299.xml · nonDerivative · entry 2

ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,194,809

F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.

F5 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Includes 236 shares purchased on November 30, 2025 through the Company's Employee Stock Purchase Plan.

F4 · balance_after: Includes the unvested portion of the reporting person's RSU grants.

Read SEC document
December 16, 2025 Filed Dec 18, 2025 17:35 UTC
Markus RichardChief Medical Officer
SaleCommon Stock 5,052 $21.88 $110,559.48
Disclosure

SEC source: 0002056093-25-000005 · wk-form4_1766097334.xml · nonDerivative · entry 1

Markus Richard · CIK 0002056093 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,141

F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Includes the unvested portion of the reporting person's RSU grants.

Read SEC document
December 16, 2025 Filed Dec 18, 2025 17:35 UTC
Tang Carolyn C.General Counsel
SaleCommon Stock 7,658 $21.88 $167,589.97
Disclosure

SEC source: 0001836662-25-000005 · wk-form4_1766097342.xml · nonDerivative · entry 1

Tang Carolyn C. · CIK 0001836662 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 131,544

F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Includes 1 share purchased on November 30, 2025 through the Company's Employee Stock Purchase Plan.

F4 · balance_after: Includes the unvested portion of the reporting person's RSU grants.

Read SEC document
December 16, 2025 Filed Dec 18, 2025 22:35 UTC
Azoy AlexanderChief Accounting Officer
SaleCommon Stock 2,376 $21.88 $51,997.10
Disclosure

SEC source: 0001771961-25-000014 · wk-form4_1766097326.xml · nonDerivative · entry 1

Azoy Alexander · CIK 0001771961 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,987

F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Includes the unvested portion of the reporting person's RSU grants.

Read SEC document
December 16, 2025 Filed Dec 18, 2025 22:35 UTC
Goeltz II Robert C.Chief Financial Officer
SaleCommon Stock 6,702 $21.88 $146,668.58
Disclosure

SEC source: 0001653881-25-000011 · wk-form4_1766097319.xml · nonDerivative · entry 1

Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 80,436

F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Includes the unvested portion of the reporting person's RSU grants.

Read SEC document
December 16, 2025 Filed Dec 18, 2025 22:35 UTC
Jarrett JenniferChief Operating Officer
SaleCommon Stock 11,225 $21.88 $245,651.27
Disclosure

SEC source: 0001671311-25-000009 · wk-form4_1766097311.xml · nonDerivative · entry 1

Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 203,007

F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Includes the unvested portion of the reporting person's RSU grants.

Read SEC document
December 16, 2025 Filed Dec 18, 2025 22:35 UTC
Jaen Juan C.President
SaleCommon Stock 11,225 $21.88 $245,651.27
Disclosure

SEC source: 0001422996-25-000015 · wk-form4_1766097305.xml · nonDerivative · entry 1

Jaen Juan C. · CIK 0001422996 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 355,995

F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Includes the unvested portion of the reporting person's RSU grants.

Read SEC document
December 16, 2025 Filed Dec 18, 2025 22:35 UTC
ROSEN TERRY JDirector · Chief Executive Officer
SaleCommon Stock 28,947 $21.88 $633,484.83
Disclosure

SEC source: 0001182473-25-000005 · wk-form4_1766097299.xml · nonDerivative · entry 1

ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,220,553

F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Includes 236 shares purchased on November 30, 2025 through the Company's Employee Stock Purchase Plan.

F4 · balance_after: Includes the unvested portion of the reporting person's RSU grants.

Read SEC document
December 16, 2025 Filed May 12, 2026 20:09 UTC
Ribas AntoniDirector
GiftCommon Stock 5,050 $0.00 $0.00
Disclosure

SEC source: 0001792164-26-000003 · wk-form4_1778616552.xml · nonDerivative · entry 1

Ribas Antoni · CIK 0001792164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,600

F1 · shares: Gift to family members for estate planning purposes.

F2 · balance_after: Includes the unvested portion of the reporting person's RSU grants.

Read SEC document
December 04, 2025 Filed Dec 5, 2025 21:15 UTC
Jaen Juan C.President
SaleCommon Stock 82,997 $24.71 $2,050,598.58
Disclosure

SEC source: 0001422996-25-000011 · wk-form4_1764969323.xml · nonDerivative · entry 1

Jaen Juan C. · CIK 0001422996 · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 954,063

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2025.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.35 to $25.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
November 26, 2025 Filed Nov 26, 2025 21:07 UTC
Goeltz II Robert C.Chief Financial Officer
SaleCommon Stock 5,000 $25.00 $125,000.00
Disclosure

SEC source: 0001653881-25-000007 · wk-form4_1764191259.xml · nonDerivative · entry 1

Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 87,138

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
November 26, 2025 Filed Dec 1, 2025 23:09 UTC
Azoy AlexanderChief Accounting Officer
Exercise / conversionStock Option (right to buy) · Derivative 1,900 $0.00 Strike: $13.33 $0.00
Disclosure

SEC source: 0001771961-25-000009 · wk-form4_1764630580.xml · derivative · entry 3

Azoy Alexander · CIK 0001771961 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,500

Underlying: Common Stock · 1,900 shares

Expires 2035-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · derivative.exercise_date: The option becomes exercisable in 48 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company.

Read SEC document
November 26, 2025 Filed Dec 1, 2025 23:09 UTC
Azoy AlexanderChief Accounting Officer
SaleCommon Stock 1,900 $26.00 $49,400.00
Disclosure

SEC source: 0001771961-25-000009 · wk-form4_1764630580.xml · nonDerivative · entry 2

Azoy Alexander · CIK 0001771961 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,363

F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
November 26, 2025 Filed Dec 1, 2025 23:09 UTC
Azoy AlexanderChief Accounting Officer
Exercise / conversionCommon Stock 1,900 $13.33 $25,327.00
Disclosure

SEC source: 0001771961-25-000009 · wk-form4_1764630580.xml · nonDerivative · entry 1

Azoy Alexander · CIK 0001771961 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,263

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
November 18, 2025 Filed Nov 19, 2025 21:39 UTC
Jaen Juan C.President
SaleCommon Stock 5,050 $19.75 $99,737.50
Disclosure

SEC source: 0001422996-25-000009 · wk-form4_1763588347.xml · nonDerivative · entry 3

Jaen Juan C. · CIK 0001422996 · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 1,037,060

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025.

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.48 to $20.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
November 17, 2025 Filed Nov 19, 2025 21:39 UTC
Jaen Juan C.President
SaleCommon Stock 7,836 $20.71 $162,307.07
Disclosure

SEC source: 0001422996-25-000009 · wk-form4_1763588347.xml · nonDerivative · entry 2

Jaen Juan C. · CIK 0001422996 · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 1,042,110

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025.

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.65 to $20.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
November 17, 2025 Filed Nov 19, 2025 21:39 UTC
Jaen Juan C.President
SaleCommon Stock 37,114 $20.23 $750,719.72
Disclosure

SEC source: 0001422996-25-000009 · wk-form4_1763588347.xml · nonDerivative · entry 1

Jaen Juan C. · CIK 0001422996 · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 1,049,946

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.65 to $20.645, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
November 07, 2025 Filed Nov 12, 2025 21:04 UTC
Jarrett JenniferChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 50,291 $1.23 Strike: $1.23 $61,737.23
Disclosure

SEC source: 0001671311-25-000005 · wk-form4_1762981456.xml · derivative · entry 3

Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 80,583

Underlying: Common Stock · 50,291 shares

Expires 2027-03-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · derivative.exercise_date: The option is fully vested and currently exercisable.

Read SEC document
November 07, 2025 Filed Nov 12, 2025 21:04 UTC
Jarrett JenniferChief Operating Officer
SaleCommon Stock 50,291 $18.97 $954,065.53
Disclosure

SEC source: 0001671311-25-000005 · wk-form4_1762981456.xml · nonDerivative · entry 2

Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 214,232

F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.59 to $19.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
November 07, 2025 Filed Nov 12, 2025 21:04 UTC
Jarrett JenniferChief Operating Officer
Exercise / conversionCommon Stock 50,291 $1.23 $61,737.23
Disclosure

SEC source: 0001671311-25-000005 · wk-form4_1762981456.xml · nonDerivative · entry 1

Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 264,523

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 21:46 UTC
Jaen Juan C.President
SaleCommon Stock 4,314 $20.32 $87,649.70
Disclosure

SEC source: 0001422996-25-000007 · wk-form4_1762206359.xml · nonDerivative · entry 1

Jaen Juan C. · CIK 0001422996 · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 1,087,060

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2024.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.12 to $20.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 12:49 UTC
Jaen Juan C.President
SaleCommon Stock 800 $22.04 $17,635.28
Disclosure

SEC source: 0001422996-25-000005 · wk-form4_1761828546.xml · nonDerivative · entry 4

Jaen Juan C. · CIK 0001422996 · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 1,091,374

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2024.

F5 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.035 to $22.055, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 12:49 UTC
Jaen Juan C.President
SaleCommon Stock 29,365 $21.53 $632,166.78
Disclosure

SEC source: 0001422996-25-000005 · wk-form4_1761828546.xml · nonDerivative · entry 3

Jaen Juan C. · CIK 0001422996 · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 1,092,174

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2024.

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.02 to $22.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 12:49 UTC
Jaen Juan C.President
SaleCommon Stock 47,675 $20.49 $976,832.15
Disclosure

SEC source: 0001422996-25-000005 · wk-form4_1761828546.xml · nonDerivative · entry 2

Jaen Juan C. · CIK 0001422996 · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 1,121,539

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2024.

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
October 28, 2025 Filed Oct 29, 2025 12:54 UTC
Goeltz II Robert C.Chief Financial Officer
SaleCommon Stock 5,000 $20.00 $100,000.00
Disclosure

SEC source: 0001653881-25-000005 · wk-form4_1761742455.xml · nonDerivative · entry 1

Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,138

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2023.

Read SEC document
October 28, 2025 Filed Oct 30, 2025 12:49 UTC
Jaen Juan C.President
SaleCommon Stock 19,019 $20.19 $383,944.16
Disclosure

SEC source: 0001422996-25-000005 · wk-form4_1761828546.xml · nonDerivative · entry 1

Jaen Juan C. · CIK 0001422996 · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 1,169,214

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2024.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
October 08, 2025 Filed Oct 8, 2025 23:08 UTC
Jarrett JenniferChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 37,792 $0.00 Strike: $1.23 $0.00
Disclosure

SEC source: 0001671311-25-000003 · wk-form4_1759964895.xml · derivative · entry 6

Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130,874

Underlying: Common Stock · 37,792 shares

Expires 2027-03-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F5 · derivative.exercise_date: The option is fully vested and currently exercisable.

Read SEC document
October 08, 2025 Filed Oct 8, 2025 23:08 UTC
Jarrett JenniferChief Operating Officer
SaleCommon Stock 37,792 $15.05 $568,610.87
Disclosure

SEC source: 0001671311-25-000003 · wk-form4_1759964895.xml · nonDerivative · entry 4

Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 214,232

F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · balance_after: Includes 863 shares purchased on 5/30/2025 through the Company's Employee Stock Purchase Plan.

Read SEC document
October 08, 2025 Filed Oct 8, 2025 23:08 UTC
Jarrett JenniferChief Operating Officer
Exercise / conversionCommon Stock 37,792 $1.23 $46,393.46
Disclosure

SEC source: 0001671311-25-000003 · wk-form4_1759964895.xml · nonDerivative · entry 3

Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 252,024

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: Includes 863 shares purchased on 5/30/2025 through the Company's Employee Stock Purchase Plan.

Read SEC document
October 06, 2025 Filed Oct 8, 2025 23:08 UTC
Jarrett JenniferChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $1.23 $0.00
Disclosure

SEC source: 0001671311-25-000003 · wk-form4_1759964895.xml · derivative · entry 5

Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 168,666

Underlying: Common Stock · 12,500 shares

Expires 2027-03-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F5 · derivative.exercise_date: The option is fully vested and currently exercisable.

Read SEC document
October 06, 2025 Filed Oct 8, 2025 23:08 UTC
Jarrett JenniferChief Operating Officer
SaleCommon Stock 12,500 $14.54 $181,801.25
Disclosure

SEC source: 0001671311-25-000003 · wk-form4_1759964895.xml · nonDerivative · entry 2

Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 214,232

F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.40 to $14.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · balance_after: Includes 863 shares purchased on 5/30/2025 through the Company's Employee Stock Purchase Plan.

Read SEC document
October 06, 2025 Filed Oct 8, 2025 23:08 UTC
Jarrett JenniferChief Operating Officer
Exercise / conversionCommon Stock 12,500 $1.23 $15,345.00
Disclosure

SEC source: 0001671311-25-000003 · wk-form4_1759964895.xml · nonDerivative · entry 1

Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 226,732

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: Includes 863 shares purchased on 5/30/2025 through the Company's Employee Stock Purchase Plan.

Read SEC document
September 29, 2025 Filed Sep 30, 2025 22:59 UTC
Azoy AlexanderChief Accounting Officer
SaleCommon Stock 2,831 $13.00 $36,803.00
Disclosure

SEC source: 0001771961-25-000006 · wk-form4_1759273140.xml · nonDerivative · entry 1

Azoy Alexander · CIK 0001771961 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,363

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2025.

Read SEC document
September 05, 2025 Filed Sep 5, 2025 23:48 UTC
Azoy AlexanderChief Accounting Officer
SaleCommon Stock 1,579 $11.88 $18,758.05
Disclosure

SEC source: 0001771961-25-000003 · wk-form4_1757116088.xml · nonDerivative · entry 1

Azoy Alexander · CIK 0001771961 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,194

F1 · shares: Consists of 1,579 shares purchased on 5/30/2025 through the Company's Employee Stock Purchase Plan.

F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2025.

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.55 to $12.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:29 UTC GrantStock Option (Right to Buy) · Derivative 38,300 $0.00 Strike: $10.02 $0.00
Disclosure

SEC source: 0001724521-25-000092 · wk-form4_1749760139.xml · derivative · entry 2

PERLMAN ANDREW J · CIK 0001201617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,300

Underlying: Common Stock · 38,300 shares

Expires 2035-06-09

F2 · derivative.exercise_date: The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:29 UTC GrantCommon Stock 13,300 $0.00 $0.00
Disclosure

SEC source: 0001724521-25-000092 · wk-form4_1749760139.xml · nonDerivative · entry 1

PERLMAN ANDREW J · CIK 0001201617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,625

F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:28 UTC GrantStock Option (Rights to Buy) · Derivative 38,300 $0.00 Strike: $10.02 $0.00
Disclosure

SEC source: 0001724521-25-000091 · wk-form4_1749760129.xml · derivative · entry 3

FALBERG KATHRYN E · CIK 0001206977 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,300

Underlying: Common Stock · 38,300 shares

Expires 2035-06-09

F2 · derivative.exercise_date: The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:28 UTC GrantCommon Stock 13,300 $0.00 $0.00
Disclosure

SEC source: 0001724521-25-000091 · wk-form4_1749760129.xml · nonDerivative · entry 1

FALBERG KATHRYN E · CIK 0001206977 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,600

F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:28 UTC GrantStock Option (Right to Buy) · Derivative 38,300 $0.00 Strike: $10.02 $0.00
Disclosure

SEC source: 0001724521-25-000090 · wk-form4_1749760118.xml · derivative · entry 2

Machado Patrick · CIK 0001311210 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,300

Underlying: Common Stock · 38,300 shares

Expires 2035-06-09

F2 · derivative.exercise_date: The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:28 UTC GrantCommon Stock 13,300 $0.00 $0.00
Disclosure

SEC source: 0001724521-25-000090 · wk-form4_1749760118.xml · nonDerivative · entry 1

Machado Patrick · CIK 0001311210 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,600

F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:28 UTC
Ribas AntoniDirector
GrantStock Option (Right to Buy) · Derivative 38,300 $0.00 Strike: $10.02 $0.00
Disclosure

SEC source: 0001724521-25-000089 · wk-form4_1749760105.xml · derivative · entry 3

Ribas Antoni · CIK 0001792164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,300

Underlying: Common Stock · 38,300 shares

Expires 2035-06-09

F2 · derivative.exercise_date: The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:28 UTC
Ribas AntoniDirector
GrantCommon Stock 13,300 $0.00 $0.00
Disclosure

SEC source: 0001724521-25-000089 · wk-form4_1749760105.xml · nonDerivative · entry 1

Ribas Antoni · CIK 0001792164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,650

F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:28 UTC GrantStock Option (Right to Buy) · Derivative 38,300 $0.00 Strike: $10.02 $0.00
Disclosure

SEC source: 0001724521-25-000088 · wk-form4_1749760091.xml · derivative · entry 2

Lacey David L. · CIK 0001734422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,300

Underlying: Common Stock · 38,300 shares

Expires 2035-06-09

F2 · derivative.exercise_date: The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:28 UTC GrantCommon Stock 13,300 $0.00 $0.00
Disclosure

SEC source: 0001724521-25-000088 · wk-form4_1749760091.xml · nonDerivative · entry 1

Lacey David L. · CIK 0001734422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,952

F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:27 UTC GrantStock Option (Right to Buy) · Derivative 38,300 $0.00 Strike: $10.02 $0.00
Disclosure

SEC source: 0001724521-25-000086 · wk-form4_1749760070.xml · derivative · entry 2

Lambert Nicole · CIK 0001770252 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,300

Underlying: Common Stock · 38,300 shares

Expires 2035-06-09

F2 · derivative.exercise_date: The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.